期刊文献+

机理性灭活体外细胞色素P450及其对体内药物相互作用定量预测的研究进展 被引量:1

Advances in predicting of drug-drug interaction in vivo by using cytochrome P450 mechanism-based inhibition data in vitro
下载PDF
导出
摘要 近10年来,以体外细胞色素P450抑制数据预测潜在临床药物相互作用的方法得到极大发展。药物相互作用(drug-drug interaction)研究一直是临床实践和新药开发中的重要环节。本文对近年来引起广泛重视的机理性灭活作用(mechanismbased inactivation)进行总结分析,综合传统和经简化的鉴定机理性灭活作用方法,并介绍预测体内由机理性灭活引起药物相互作用的模型和影响参数。 In the last decade, the approaches for the in vitro inhibition assessment of the potentials of drug-drug interaction in vivo have received process. DDIs remain an important issue in clinical practice and the development of new drugs. Mechanism-based inactivation is gaining more attention among in vitro study. This review would describe methods in identifying mechanism-based inactivation, and introduce predictive models and parameters in the field.
作者 曹杉 周宏灏
出处 《中国临床药理学与治疗学》 CAS CSCD 2008年第3期241-248,共8页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 药物相互作用 不可逆性抑制 机理性灭活 细胞色素P450 体外一体外预测 drug-drug interaction irreversible inhibition mechanism-based inactivation cytochrome P450 in vitroin vivo extrapolation
  • 相关文献

参考文献31

  • 1Ripp SL, Mills JB, Fahmi OA, et al. Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction [ J]. Drug Metab Dispos, 2006,34(10) : 1742 - 1748. 被引量:1
  • 2Bera AK, Polovnikova LS, Roestamadji J, et al. Mechanism-based inactivation of benzoylformate decarboxylase, a thiamin diphosphate-dependent enzyme [ J]. J Am Chem Soc, 2007, 129(14) :4120 - 4121. 被引量:1
  • 3Ito K, Brown HS, Houston JB. Database analyses for the prediction of in vivo drug-drug interactions from in vitro data[J]. Br J Clin Pharmacol, 2004,57(4):473- 486. 被引量:1
  • 4Ito K, Ogihara K, Kanamitsu S, et al. Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes[J]. Drug Metab Dispos, 2003,31 (7) : 945 - 954. 被引量:1
  • 5Obach RS, Walsky RL, Venkatakrishnan K, et al. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions [ J ]. J Pharmacol Exp Ther, 2006,316(1) :336- 348. 被引量:1
  • 6Massey V, Edmondson D. On the mechanism of inactivation of xanthine oxidase by cyanide [ J ]. J Biol Chem, 1970,245 (24) : 6595 - 6598. 被引量:1
  • 7Rando RR. Mechanism-based enzyme inactivators [ J ]. Pharmacol Rev, 1984,36(2):111 - 142. 被引量:1
  • 8Kent UM, Juschyshyn MI, Hollenberg PF. Mechanismbased inactivators as probes of cytochrome P450 structure and function[J]. Curr Drug Metab, 2001,2(3) : 215 - 243. 被引量:1
  • 9Bertelsen KM, Venkatakrishnan K, Von Moltke LL, et al. Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine[J]. Drug Metab Dispos, 2003,31(3): 289- 293. 被引量:1
  • 10Harleton E, Webster M, Bumpus NN, et al. Metabolism of N, N', N”-triethylenethiophosphoramide by CYP2B1 and CTP2B6 results in the inactivation of both isoforms by two distinct mechanisms[J]. J Pharmacol Exp Ther, 2004,310 (3) : 1011 - 1019. 被引量:1

同被引文献23

  • 1Pelkonen O, Turpeinen M, Uusitalo I, et al. Prediction of Drug Me- tabolism and Interactions on the Basis of in vitro Investigations [ J]. Basic & Clinical Pharmacology & Toxicology, 2005, 96 : 167-175. 被引量:1
  • 2Plant N. Strategies for using in vitro screens in drug metabolism[ J]. Drug Discovery Today, 2004, 9:328-336. 被引量:1
  • 3Kim M J, Kim H, Cha I J, et al. High-throughput screening of inhibi- tory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry [ J ]. Mass Spectrom, 2005, 19:2651-2658. 被引量:1
  • 4Salonen JS, Nyman L, Boobis AR, et al. Comparative studies on the CYP-associated metabolism and interaction potential of selegiline be- tween human liver-derived in vitro systems [ J ]. Drug Metab Dispos, 2003, 31 : 1093-1102. 被引量:1
  • 5Nebert DW, Russell DW. Clinical importance of the cytochromes P450[J]. Lancet, 2002, 360:1155-1162. 被引量:1
  • 6Obach RS, Walsky RL, Venkatakrishnan K, et al. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions [J]. J Pha-ol Exp Ther, 2006, 316:336-348. 被引量:1
  • 7Brown HS, Ito K, Galetin A, et al. Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel path- ways of drug elimination and inhibitor absorption rate constant [ J ]. Br J Clin Pharmacol, 2005, 60:508-518. 被引量:1
  • 8Einolf HJ. Comparison of different approaches to predict metabolic drug-drug interactions [ J]. Xenobiotica, 2007, 37 : 1257-1294. 被引量:1
  • 9Shardlow CE, Generaux GT, Mac lmuehlin CC, et al. Utilizing drug- drug interaction prediction tools during drug development: enhanced decision making based on clinical risk [ J ]. Drug Metab Dispos, 2011, 39:2076-2084. 被引量:1
  • 10Bera AK, Polovnikova IS, Roestamadji J, et al. Mechanism-based inactivation of benzoylformate decarboxylase, a thiamin diphosphate- dependent enzyme[ J ]. J Am Chem Soc, 2007, 129 (14) :4120-4121. 被引量:1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部